Form4.ai tracks every SEC insider trade in real time. See every OCUL insider filing with a free account — no card.
See every OCUL insider filing — free account, no card.
Free accountOCULAR THERAPEUTIX, INC (OCUL) has 8 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 8 sales totalling $568K. Most recent filing: Oct. 13, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 13, 2026 SEC filing | Anderman Todd Chief Legal Officer | Sold | $87,363 | — |
| Oct 6, 2026 SEC filing | Heier Jeffrey S. Chief Scientific Officer | Sold | $76,626 | — |
| Oct 6, 2026 SEC filing | Kaiser Peter Chief Development Officer | Sold | $70,430 | — |
Create a free account to see all 8 OCUL filings from the last 90 days. No card needed.
Create free accountWant OCUL insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.